MedTrace Logo

A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Study on the Treatment of Depression with Jieyu Chufan Capsules

NCT06749470 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 480

Last updated 2024-12-27

No results posted yet for this study

Summary

To evaluate the efficacy of Jieyu Chufan Capsules, with placebo as the control, in combination with SSRIs in patients with moderate and severe depression.

To observe the safety of Jieyu Chufan Capsules and its effects in improving the side effects of SSRIs.

Conditions

  • Major Depressive Disorder (MDD)

Interventions

DRUG

Jieyu Chufan Capsules

4 capsules, tid; 8 weeks

DRUG

Jieyu Chufan Capsules simulant

4 capsules, tid; 8 weeks

Sponsors & Collaborators

  • Central South University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-22
Primary Completion
2026-12-31
Completion
2026-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06749470 on ClinicalTrials.gov